Bernard Bagaya holds a Bachelor of Biomedical Laboratory Technology (BBLT) and a Master of Science in Molecular Biology from Makerere University, Kampala, Uganda. He graduated in May 2014 with a PhD in Molecular Virology at Case Western Reserve University, Cleveland, Ohio, USA. Bagaya has more than 13 years' experience in HIV research and Vaccine clinical trials. He currently doubles as the Laboratory Director and Acting Executive Director at Uganda Virus Research Institute-International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Programme, Entebbe, Uganda. He is also faculty at Makerere University College of Health Sciences (MakCHS), Department of Immunology and Molecular Biology. His research involves the study of B cell (antibody) responses against the HIV envelopes, particularly longitudinal development of broadly neutralising antibodies. He is also interested in immune modulation by socio-behavioral factors such as alcohol consumption, and the role they play in HIV susceptibility or responses to vaccines particularly in most-at-risk populations. He has vast expertise in laboratory medicine, he is a licensed medical laboratory practitioner and consultant with vast experience in Laboratory Quality Management Systems and Strengthening and Accreditation guidelines on several standards including ISO15189, CAP and GCLP.